Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that for hair and feather growth, it's better to target the environment around stem cells than the cells themselves.

Glucocorticoids and sex hormones affect skin health, with potential for targeted treatments to minimize side effects and treat skin conditions.

New treatments and diagnostic methods for various animal skin conditions showed promising results.

PCOS may start before birth, involves metabolic issues, and can be treated with drugs like metformin and lifestyle changes.

Men with less sun-sensitive skin have lower PSA levels, while men with more sun-sensitive skin have higher PSA levels.

PCOS is the most common cause of hirsutism, and personalized treatment is important.

Androgens can both stimulate and cause hair loss, and understanding their effects is key to treating hair disorders.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

A new gene mutation causes female pseudohermaphroditism due to glucocorticoid resistance.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

Certain ESR1 gene variations may affect hormone levels and fat distribution in women with high male hormone levels.

AGA, a common hair loss, is caused by genetics, hormones, age, and environmental factors.

Finasteride can have lasting negative effects on brain function and behavior by disrupting neurosteroid production.

Minocycline may cause hair loss by increasing DHT levels, but finasteride can help counteract this effect.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

Lower adrenal hormone levels may cause hair loss in postmenopausal women, certain patterns help diagnose nail cancer, and a gene variant linked to higher skin cancer risk in kidney transplant patients suggests monitoring folate levels.

Obesity is linked to various skin conditions and issues, and losing weight can improve these conditions.

Low testosterone levels may lead to more severe COVID-19 outcomes.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Changing protein kinase levels in pituitary cells affects calcium flow and beta-endorphin release.

Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

PCOS is caused by both genetics and environmental factors like diet and obesity.

Patients with androgenetic alopecia have thinner subcutaneous fat layers in their frontal scalp compared to healthy individuals.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

Skin lesions in Carney Complex are caused by a gene change in some skin cells that leads to increased pigmentation and may lead to tumors.

Use trichoscopy to diagnose hair loss; treat with minoxidil, finasteride, or dutasteride; consider platelet-rich plasma and spironolactone.

A group has developed therapies that show promise for treating cancer and various other conditions.

Hair growth is influenced by hormones and goes through different phases; androgens can both promote and inhibit hair growth depending on the body area.

Future treatments for androgenic alopecia may focus on reactivating hair follicle stem cells and improving drug delivery.